• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯喹对猫传染性腹膜炎病毒感染的体外和体内影响。

Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo.

机构信息

Laboratory of Veterinary Infectious Disease, School of Veterinary Medicine, Kitasato University, Towada, Aomori 034-8628, Japan.

出版信息

Antiviral Res. 2013 Aug;99(2):100-7. doi: 10.1016/j.antiviral.2013.04.016. Epub 2013 May 3.

DOI:10.1016/j.antiviral.2013.04.016
PMID:23648708
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7114111/
Abstract

Feline infectious peritonitis (FIP) is a feline coronavirus-induced fatal disease in domestic and wild cats. Several studies have investigated potential treatments for FIP. However, there have been no reports on agents that have exhibited a therapeutic effect. Recently, chloroquine has been reported to antiviral effect. We investigated whether chloroquine can be used to treat FIP in vitro and in vivo. It was demonstrated that chloroquine has inhibitory effect against the replication of FIPV and anti-inflammatory effect in vitro. In vivo study using cats with experimentally induced FIP, the clinical score of chloroquine-treatment groups were better than in chloroquine-untreated group. However, alanine aminotransferase levels increased in the chloroquine-treated groups. It will be necessary to further investigate the possibility of FIP treatment with a combination of chloroquine and other agents.

摘要

猫传染性腹膜炎(FIP)是一种由猫冠状病毒引起的致命疾病,在国内外的猫中均有发生。已有多项研究探索了 FIP 的潜在治疗方法,但尚未有报道称有哪种药物具有治疗效果。最近有报道称氯喹具有抗病毒作用。我们研究了氯喹是否可以在体外和体内用于治疗 FIP。结果表明,氯喹在体外具有抑制 FIPV 复制和抗炎作用。在使用实验性诱导 FIP 的猫进行的体内研究中,氯喹治疗组的临床评分优于未用氯喹治疗组。然而,氯喹治疗组的丙氨酸氨基转移酶水平升高。需要进一步研究氯喹与其他药物联合治疗 FIP 的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/709302a345ac/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/d6fbb63ae0fa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/ca6b6e2411e5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/1d54e32d216d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/2a2ea3c691c5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/03cd33539290/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/6068b07e8b4f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/709302a345ac/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/d6fbb63ae0fa/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/ca6b6e2411e5/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/1d54e32d216d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/2a2ea3c691c5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/03cd33539290/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/6068b07e8b4f/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/177b/7114111/709302a345ac/gr7.jpg

相似文献

1
Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo.氯喹对猫传染性腹膜炎病毒感染的体外和体内影响。
Antiviral Res. 2013 Aug;99(2):100-7. doi: 10.1016/j.antiviral.2013.04.016. Epub 2013 May 3.
2
The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies.核苷类似物 GS-441524 能在组织培养和实验猫感染研究中强烈抑制猫传染性腹膜炎(FIP)病毒。
Vet Microbiol. 2018 Jun;219:226-233. doi: 10.1016/j.vetmic.2018.04.026. Epub 2018 Apr 22.
3
Identification of the peptide derived from S1 domain that inhibits type I and type II feline infectious peritonitis virus infection.鉴定源自S1结构域的可抑制I型和II型猫传染性腹膜炎病毒感染的肽。
Virus Res. 2015 Jun 2;204:13-20. doi: 10.1016/j.virusres.2015.04.011. Epub 2015 Apr 18.
4
Establishment of Full-Length cDNA Clones and an Efficient Oral Infection Model for Feline Coronavirus in Cats.建立全长 cDNA 克隆及猫冠状病毒在猫中的高效口服感染模型。
J Virol. 2021 Oct 13;95(21):e0074521. doi: 10.1128/JVI.00745-21. Epub 2021 Aug 18.
5
Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.羟氯喹和 I 型干扰素对体外致死性猫冠状病毒感染的抗病毒作用。
Viruses. 2020 May 24;12(5):576. doi: 10.3390/v12050576.
6
Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor.一种广谱冠状病毒蛋白酶抑制剂可逆转猫致命性冠状病毒感染的进程。
PLoS Pathog. 2016 Mar 30;12(3):e1005531. doi: 10.1371/journal.ppat.1005531. eCollection 2016 Mar.
7
Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524.用含有 GS-441524 的口服多组分药物治疗猫传染性腹膜炎。
Viruses. 2021 Nov 5;13(11):2228. doi: 10.3390/v13112228.
8
In vitro antiviral effects of GS-441524 and itraconazole combination against feline infectious peritonitis virus.体外抗猫传染性腹膜炎病毒的 GS-441524 和伊曲康唑联合用药的效果。
Res Vet Sci. 2022 May;144:27-33. doi: 10.1016/j.rvsc.2022.01.005. Epub 2022 Jan 7.
9
Identification and characterisation of small molecule inhibitors of feline coronavirus replication.猫冠状病毒复制小分子抑制剂的鉴定与表征
Vet Microbiol. 2014 Dec 5;174(3-4):438-447. doi: 10.1016/j.vetmic.2014.10.030. Epub 2014 Nov 4.
10
ERDRP-0519 inhibits feline coronavirus in vitro.ERDRP-0519 在体外抑制猫冠状病毒。
BMC Vet Res. 2022 Jan 25;18(1):55. doi: 10.1186/s12917-022-03153-3.

引用本文的文献

1
Waste Biochar in Batch and Fixed-Bed Adsorption of Chloroquine Phosphate: Efficacy Validation Using Artificial Neural Networks.废生物炭对磷酸氯喹的间歇式和固定床吸附:使用人工神经网络进行功效验证
ACS Omega. 2024 Mar 6;9(11):12564-12574. doi: 10.1021/acsomega.3c05008. eCollection 2024 Mar 19.
2
Feline Infectious Peritonitis: European Advisory Board on Cat Diseases Guidelines.猫传染性腹膜炎:欧洲猫病咨询委员会指南。
Viruses. 2023 Aug 31;15(9):1847. doi: 10.3390/v15091847.
3
The Penn Medicine COVID-19 Therapeutics Committee-Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations During a Public Health Emergency.

本文引用的文献

1
Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines.人冠状病毒 EMC 并不需要 SARS 冠状病毒受体,并且在哺乳动物细胞系中保持广泛的复制能力。
mBio. 2012 Dec 11;3(6):e00515-12. doi: 10.1128/mBio.00515-12.
2
Potent inhibition of feline coronaviruses with peptidyl compounds targeting coronavirus 3C-like protease.肽类化合物靶向冠状病毒 3C 样蛋白酶对猫冠状病毒的强效抑制作用。
Antiviral Res. 2013 Feb;97(2):161-8. doi: 10.1016/j.antiviral.2012.11.005. Epub 2012 Nov 28.
3
Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal model.
宾夕法尼亚大学医学部新冠治疗委员会——关于公共卫生紧急事件期间快速证据审查及动态实践建议模式的思考
Open Forum Infect Dis. 2023 Aug 9;10(8):ofad428. doi: 10.1093/ofid/ofad428. eCollection 2023 Aug.
4
Rottlerin-Liposome Inhibits the Endocytosis of Feline Coronavirus Infection.罗勒酮脂质体抑制猫冠状病毒感染的内吞作用。
Vet Sci. 2023 May 30;10(6):380. doi: 10.3390/vetsci10060380.
5
Subversion of autophagy machinery and organelle-specific autophagy by SARS-CoV-2 and coronaviruses.SARS-CoV-2 和冠状病毒对自噬机制和细胞器特异性自噬的颠覆作用。
Autophagy. 2023 Apr;19(4):1055-1069. doi: 10.1080/15548627.2022.2116677. Epub 2022 Aug 31.
6
ERDRP-0519 inhibits feline coronavirus in vitro.ERDRP-0519 在体外抑制猫冠状病毒。
BMC Vet Res. 2022 Jan 25;18(1):55. doi: 10.1186/s12917-022-03153-3.
7
Therapeutic Effects of Mutian Xraphconn on 141 Client-Owned Cats with Feline Infectious Peritonitis Predicted by Total Bilirubin Levels.根据总胆红素水平预测木天蓼对141只患猫传染性腹膜炎的宠物猫的治疗效果
Vet Sci. 2021 Dec 13;8(12):328. doi: 10.3390/vetsci8120328.
8
Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines.新型冠状病毒肺炎治疗与预防干预措施的最新进展:潜在药物及疫苗概述
Mol Biomed. 2020;1(1):16. doi: 10.1186/s43556-020-00017-w. Epub 2020 Dec 3.
9
Feline Coronavirus Antivirals: A Review.猫冠状病毒抗病毒药物:综述
Pathogens. 2021 Sep 7;10(9):1150. doi: 10.3390/pathogens10091150.
10
Animal Coronavirus Diseases: Parallels with COVID-19 in Humans.动物冠状病毒病:与人类 COVID-19 的相似之处。
Viruses. 2021 Jul 30;13(8):1507. doi: 10.3390/v13081507.
抗疟疾药物氯喹在动物模型中对治疗甲型H5N1禽流感病毒感染非常有效。
Cell Res. 2013 Feb;23(2):300-2. doi: 10.1038/cr.2012.165. Epub 2012 Dec 4.
4
Reduction of immune activation with chloroquine therapy during chronic HIV infection.氯喹治疗慢性 HIV 感染期间免疫激活的减少。
J Virol. 2010 Nov;84(22):12082-6. doi: 10.1128/JVI.01466-10. Epub 2010 Sep 15.
5
Synergistic antiviral effect of Galanthus nivalis agglutinin and nelfinavir against feline coronavirus.雪绒花凝集素与奈非那韦协同抗猫冠状病毒的作用。
Antiviral Res. 2010 Oct;88(1):25-30. doi: 10.1016/j.antiviral.2010.06.010. Epub 2010 Aug 23.
6
Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus.磷酸氯喹治疗对系统性红斑狼疮患者血清 MMP-9 和 TIMP-1 水平的影响。
Lupus. 2010 May;19(6):683-8. doi: 10.1177/0961203309356455. Epub 2010 Jan 11.
7
Chloroquine administration does not prevent Nipah virus infection and disease in ferrets.氯喹给药不能预防雪貂感染尼帕病毒及发病。
J Virol. 2009 Nov;83(22):11979-82. doi: 10.1128/JVI.01847-09. Epub 2009 Sep 16.
8
Chloroquine is effective against influenza A virus in vitro but not in vivo.氯喹在体外对甲型流感病毒有效,但在体内无效。
Influenza Other Respir Viruses. 2007 Sep-Nov;1(5-6):189-92. doi: 10.1111/j.1750-2659.2007.00027.x.
9
Neutrophil survival factors (TNF-alpha, GM-CSF, and G-CSF) produced by macrophages in cats infected with feline infectious peritonitis virus contribute to the pathogenesis of granulomatous lesions.感染猫传染性腹膜炎病毒的猫体内,巨噬细胞产生的中性粒细胞存活因子(肿瘤坏死因子-α、粒细胞-巨噬细胞集落刺激因子和粒细胞集落刺激因子)会促使肉芽肿性病变的形成。
Arch Virol. 2009;154(5):775-81. doi: 10.1007/s00705-009-0371-3. Epub 2009 Apr 3.
10
A review of feline infectious peritonitis virus infection: 1963-2008.猫传染性腹膜炎病毒感染综述:1963 - 2008年
J Feline Med Surg. 2009 Apr;11(4):225-58. doi: 10.1016/j.jfms.2008.09.008. Epub 2009 Feb 28.